Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_assertion description "[Thus, targeting CD164 may serve as a potential ovarian cancer biomarker, and targeting CD164 may serve as a therapeutic modality in the management of high-grade ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_assertion evidence source_evidence_literature NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_assertion SIO_000772 24094005 NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_assertion wasDerivedFrom befree-20150227 NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_assertion wasGeneratedBy ECO_0000203 NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP804712.RA-Y8L6synilIn1SITSqA-Vk84XVXcsHUMYucIk53OYUs130_provenance.